Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 6,390.00
-190.00 (-2.89%)
Sep 1, 2026, 3:30 PM KST
Hyundai Bioscience Market Cap
Hyundai Bioscience has a market cap or net worth of 634.99 billion as of September 1, 2026. Its market cap has increased by 8.75% in one year.
Market Cap
634.99B
Enterprise Value
615.21B
Revenue
3.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,390.00
ChartMarket Cap Chart
Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 634.99B, an increase of 1,236.99%. That is a compound annual growth rate of 11.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 616.66B | 29.32% |
| Dec 30, 2025 | 476.83B | -15.13% |
| Dec 30, 2024 | 561.85B | -45.92% |
| Dec 28, 2023 | 1.04T | -4.44% |
| Dec 29, 2022 | 1.09T | 11.39% |
| Dec 30, 2021 | 976.10B | -6.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 754.82B |
| Pharmicell | 673.25B |
| Onconic Therapeutics | 670.67B |
| Komipharm International | 669.89B |
| GI Innovation | 521.93B |
| AbClon | 519.75B |
| Medy-Tox | 463.40B |
| GC Corp. | 460.37B |